---
title: "This Rollins Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293611708.md"
description: "Several Wall Street analysts downgraded major stocks on Thursday. Keefe, Bruyette & Woods downgraded WesBanco to Market Perform. Evercore ISI downgraded Zions Bancorporation to Underperform with a lower price target. B of A Securities downgraded Rollins from Buy to Underperform, cutting its price target significantly. Keybanc downgraded Pegasystems to Sector Weight, and Citigroup downgraded Agilon Health to Sell."
datetime: "2026-07-23T11:46:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293611708.md)
  - [en](https://longbridge.com/en/news/293611708.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293611708.md)
---

# This Rollins Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Keefe, Bruyette & Woods analyst Catherine Mealor downgraded **WesBanco Inc** (NASDAQ:WSBC) from Outperform to Market Perform and maintained the price target of $42. Wesbanco shares closed at $40.91 on Wednesday. See how other analysts view this stock.
-   Evercore ISI Group analyst John Pancari downgraded **Zions Bancorporation** (NASDAQ:ZION) from In-Line to Underperform and cut the price target from $74 to $68. Zions Bancorp shares closed at $70.07 on Wednesday. See how other analysts view this stock.
-   B of A Securities analyst Curtis Nagle downgraded **Rollins Inc** (NYSE:ROL) from Buy to Underperform and cut the price target from $55 to $35. Rollins shares closed at $43.47 on Wednesday. See how other analysts view this stock.
-   Keybanc analyst Devin Au downgraded **Pegasystems Inc** (NASDAQ:PEGA) from Overweight to Sector Weight. Pegasystems shares closed at $25.99 on Wednesday. See how other analysts view this stock.
-   Citigroup analyst Daniel Grosslight downgraded **Agilon Health Inc** (NYSE:AGL) from Neutral to Sell and raised the price target from $80 to $105. Agilon Health shares closed at $119.88 on Wednesday. See how other analysts view this stock.

Considering buying ROL stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [AGL.US](https://longbridge.com/en/quote/AGL.US.md)
- [ZION.US](https://longbridge.com/en/quote/ZION.US.md)
- [PEGA.US](https://longbridge.com/en/quote/PEGA.US.md)
- [ROL.US](https://longbridge.com/en/quote/ROL.US.md)
- [WSBC.US](https://longbridge.com/en/quote/WSBC.US.md)
- [WSBCO.US](https://longbridge.com/en/quote/WSBCO.US.md)
- [ZIONP.US](https://longbridge.com/en/quote/ZIONP.US.md)

## Related News & Research

- [Rollins Analysts Cut Their Forecasts After Downbeat Q2 Earnings](https://longbridge.com/en/news/293753877.md)
- [Pegasystems Analysts Cut Their Forecasts After Downbeat Q2 Earnings](https://longbridge.com/en/news/293616574.md)
- [Rollins (ROL) Stock Faces High P/E As Net Margin Slightly Undercuts Bullish Narratives](https://longbridge.com/en/news/293762894.md)
- [Analyst Maintains Buy on Rollins with Unchanged $67 Price Target Despite Near-Term Margin Pressure](https://longbridge.com/en/news/293639729.md)
- [Top Executive’s Latest Stock Move Sends Signals on Zions Bancorporation](https://longbridge.com/en/news/294290050.md)